{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:28:05Z","timestamp":1789154885433,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.anndiagpath.2021.151742","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T13:20:58Z","timestamp":1617196858000},"page":"151742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Aryl hydrocarbon receptor interacting protein (AIP) significantly influences prognosis of pancreatic carcinoma"],"prefix":"10.1016","volume":"53","author":[{"given":"M.J.","family":"Fern\u00e1ndez-Ace\u00f1ero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Barderas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pel\u00e1ez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mart\u00ednez-Useros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"D\u00edez-Valladares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"P\u00e9rez-Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ortega Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"de la Serna Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Garc\u00eda-Botella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"D\u00edaz del Arco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2021.151742_bb0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejphar.2018.07.034","article-title":"Molecular targeted therapy: treating cancer with specificity","volume":"834","author":"Lee","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0010","first-page":"1045","article-title":"The trastuzumab era: current and upcoming targeted HER2+ breast cancer therapies","volume":"10","author":"Kreutzfeldt","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0015","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0020","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0025","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2016.12.035","article-title":"Pancreatic cancer: stroma and its current and emerging targeted therapies","volume":"391","author":"Kota","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41571-019-0281-6","article-title":"From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer","volume":"17","author":"Nevala-Plagemann","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0035","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrc3621","article-title":"bHLH-PAS proteins in c\u00e1ncer","volume":"13","author":"Bersten","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0040","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.toxlet.2015.02.005","article-title":"Ligand-independent activation of aryl hydrocarbon receptor signaling in PCB3-quinone treated HaCaT human keratinocytes","volume":"233","author":"Xiao","year":"2015","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0045","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrc3621","article-title":"bHLH-PAS proteins in c\u00e1ncer","volume":"13","author":"Bersten","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2121-10-27","article-title":"Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase 9","volume":"10","author":"Peng","year":"2009","journal-title":"BMC Cell Biol"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/carcin\/bgp222","article-title":"Activation of the aryl hydrocarbon receptor pathway enhances c\u00e1ncer cell invasion by upregulating the MMP expression and is associated with por prognosis in upper urinary tract urothelial c\u00e1ncer","volume":"31","author":"Ishida","year":"2010","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.anndiagpath.2021.151742_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010145","article-title":"The aryl hydrocarbon receptor is expressed in thyroid carcinoma and appears to mediate epithelial-mesenchymal-transition","volume":"12","author":"Moretti","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0065","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.celrep.2019.04.014","article-title":"Aryl hydrocarnon receptor interacting protein maintains germinal center B cells through suprression of BCL6 degradation","volume":"27","author":"Sun","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0070","doi-asserted-by":"crossref","unstructured":"Trivellin G, Butz H, Delhove J, Igreja S, Chabal HS, Zivkovic V et al. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interactinv protein in vitro. J Physiol Endocrinol Metab 2012; 303: E708-E719.","DOI":"10.1152\/ajpendo.00546.2011"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0075","first-page":"197","article-title":"Role of aryl hydrocarbon receptor in cancer","volume":"1836","author":"Feng","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0080","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1677\/ERC-09-0094","article-title":"Expression of aryl hydrocarbon (AHR) and AHR interacting protein in pituitary adenomas: pathological and clinical implications","volume":"16","author":"Jaffrain-Rea","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000322787","article-title":"Low aryl hydrocarbon receptor interacting expression is a better marker of invasiveness in somatotropinomas than Ki67 and p53","volume":"94","author":"Kasuki Jomori de Pinho","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0090","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.bjc.6603573","article-title":"Mutation analysis of aryl hidrocarbon receptor interacting protein (AIP) gene in colorectal, breast and prostate cancers","volume":"96","author":"Georgitsi","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224613","article-title":"Insight into the relationship between aryl-hydrocarbon receptor and b-catenin in human colon cancer cells","volume":"14","author":"Shiizaki","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0100","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/hpb.12201","article-title":"A biological basis for depression in pancreatic cancer","volume":"16","author":"Botwinick","year":"2014","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000186051","article-title":"Epigenetic silencing of microRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer","volume":"9","author":"Lee","year":"2009","journal-title":"Pancreatology"},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0110","first-page":"3953","article-title":"Prognostic value of nuclear translocation of aryl hydrocarbon receptor for non-small cell lung cancer","volume":"33","author":"Su","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.anndiagpath.2021.151742_bb0115","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1677\/ERC-09-0054","article-title":"The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy","volume":"16","author":"Zhang","year":"2009","journal-title":"Endocr Relat Cancer"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913421000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:32:19Z","timestamp":1761078739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913421000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":23,"alternative-id":["S1092913421000423"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151742","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aryl hydrocarbon receptor interacting protein (AIP) significantly influences prognosis of pancreatic carcinoma","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151742"}}